These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemoenzymatic Glycan Remodeling of Natural and Recombinant Glycoproteins. Yang Q; Wang LX Methods Enzymol; 2017; 597():265-281. PubMed ID: 28935106 [TBL] [Abstract][Full Text] [Related]
4. In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Kommineni V; Markert M; Ren Z; Palle S; Carrillo B; Deng J; Tejeda A; Nandi S; McDonald KA; Marcel S; Holtz B Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621113 [TBL] [Abstract][Full Text] [Related]
5. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Strasser R; Stadlmann J; Schähs M; Stiegler G; Quendler H; Mach L; Glössl J; Weterings K; Pabst M; Steinkellner H Plant Biotechnol J; 2008 May; 6(4):392-402. PubMed ID: 18346095 [TBL] [Abstract][Full Text] [Related]
6. One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes. Tong X; Li T; Orwenyo J; Toonstra C; Wang LX Bioorg Med Chem; 2018 Apr; 26(7):1347-1355. PubMed ID: 28789910 [TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose. Jansing J; Sack M; Augustine SM; Fischer R; Bortesi L Plant Biotechnol J; 2019 Feb; 17(2):350-361. PubMed ID: 29969180 [TBL] [Abstract][Full Text] [Related]
8. Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production. Li J; Stoddard TJ; Demorest ZL; Lavoie PO; Luo S; Clasen BM; Cedrone F; Ray EE; Coffman AP; Daulhac A; Yabandith A; Retterath AJ; Mathis L; Voytas DF; D'Aoust MA; Zhang F Plant Biotechnol J; 2016 Feb; 14(2):533-42. PubMed ID: 26011187 [TBL] [Abstract][Full Text] [Related]
9. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Jin C; Altmann F; Strasser R; Mach L; Schähs M; Kunert R; Rademacher T; Glössl J; Steinkellner H Glycobiology; 2008 Mar; 18(3):235-41. PubMed ID: 18203810 [TBL] [Abstract][Full Text] [Related]
10. Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori). Tada M; Tatematsu K; Ishii-Watabe A; Harazono A; Takakura D; Hashii N; Sezutsu H; Kawasaki N MAbs; 2015; 7(6):1138-50. PubMed ID: 26261057 [TBL] [Abstract][Full Text] [Related]
11. Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodies. Li T; Li C; Quan DN; Bentley WE; Wang LX Carbohydr Res; 2018 Mar; 458-459():77-84. PubMed ID: 29475193 [TBL] [Abstract][Full Text] [Related]
12. Glycosylation control technologies for recombinant therapeutic proteins. Gupta SK; Shukla P Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089 [TBL] [Abstract][Full Text] [Related]
13. Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation. Yang Q; An Y; Zhu S; Zhang R; Loke CM; Cipollo JF; Wang LX ACS Chem Biol; 2017 Jun; 12(6):1665-1673. PubMed ID: 28452462 [TBL] [Abstract][Full Text] [Related]
14. Glycosylation of Plant-Produced Immunoglobulins. Göritzer K; Strasser R Exp Suppl; 2021; 112():519-543. PubMed ID: 34687021 [TBL] [Abstract][Full Text] [Related]
15. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Hodoniczky J; Zheng YZ; James DC Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047 [TBL] [Abstract][Full Text] [Related]